H., B., G.M., F., S., M., R.A., G., J.R., D., G.J., C., . . . S'PORE, D. G. M. S. (2016). Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (The MINIMISE STEMI Trial): Rationale and Study Design. John Wiley and Sons Inc.
Chicago Style CitationH., Bulluck, et al. Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design. John Wiley and Sons Inc, 2016.
MLA引文H., Bulluck, et al. Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design. John Wiley and Sons Inc, 2016.